Atlas Trials

Post-Marketing Surveillance Study on the Safety and Efficacy of Cymbalta (Duloxetine) on Diabetic Peripheral Neuropathic Pain Among Filipino Patients

Clinical trial NCT02215798 · COMPLETED

Trial details

NCT number
NCT02215798
Sponsor
Boehringer Ingelheim
Status
COMPLETED
Study type
OBSERVATIONAL
Pain
Start date
2006-07-01
Primary completion
2009-10-01
Enrollment
269

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.